speb/financial-data huggingface dataset:
Financial ratios for BCS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.7
Shares outstanding: 3371677916
Market cap (USD): 39448631617.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.8
Shares outstanding: 3371677916
Market cap (USD): 43157477324.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCS — annual report dated 2024-12-31
Total revenue: 32787500000
Net income: 7945000000
Capital expenditures: 1967500000
Operating cash flow: 8891250000
Depreciation & amortization: 2125000000
Net tangible assets: 79432500000
Owner earnings: 8102500000
Return on net tangible assets (%): 10.200484688257326
Buffett classification: The Gruesome
Stock price: 12.8
P/E ratio: 5.43202987096287
Shares outstanding: 3371677916
Book value: 90601250000
P/B ratio: 0.47634527475945426
Market cap (USD): 43157477324.8
Debt to equity: 2.5626853934134464
Effective tax rate (%): 21.608288110508138
COGS to revenue (%): 0
SG&A to revenue (%): 10.5604269919939
Free cash flow (dilution-adjusted): 6923750000
Buyback yield (%): 14.58032394396713
Retained earnings: 70035000000
Capitalized R&D asset: 0
FCF margin (%): 21.117041555470838
Revenue growth (%): 2.0411479672234556
Rule of 40 score: 23.158189522694293
Financial ratios for BCS — quarterly report dated 2025-03-31
Total revenue: 10011688311.68831
Net income: 2724675324.6753244
Capital expenditures: 0
Net tangible assets: 86532467532.46753
Owner earnings: 2724675324.6753244
Return on net tangible assets (%): 3.1487318024913704
Buffett classification: The Gruesome
Stock price: 15.06
P/E ratio: 4.659038542602384
Shares outstanding: 3371677916
Book value: 98103896103.896
P/B ratio: 0.5175887139200324
Market cap (USD): 50777469414.96
Debt to equity: 1.4631453534551246
Effective tax rate (%): 22.839279146745127
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 74572727272.72726
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCS — quarterly report dated 2025-06-30
Total revenue: 9845205479.452055
Net income: 2646575342.4657536
Capital expenditures: 0
Net tangible assets: 92767123287.67123
Owner earnings: 2646575342.4657536
Return on net tangible assets (%): 2.8529238038984053
Buffett classification: The Gruesome
Stock price: 18.22
P/E ratio: 11.437182033847995
Shares outstanding: 3371677916
Book value: 104595890410.95874
P/B ratio: 0.5873268193248598
Market cap (USD): 61431971629.52
Debt to equity: 1.5380656145635543
Effective tax rate (%): 22.222222222222225
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 79104109589.04109
Capitalized R&D asset: 0
Revenue growth (%): -1.6628846909056538
Rule of 40 score: -1.6628846909056538
Financial ratios for BCS — quarterly report dated 2025-09-30
Total revenue: 9685135135.135136
Net income: 2313513513.5135136
Capital expenditures: 0
Net tangible assets: 92079729729.72974
Owner earnings: 2313513513.5135136
Return on net tangible assets (%): 2.51251119036088
Buffett classification: The Gruesome
Stock price: 20.43
P/E ratio: 8.963629618887339
Shares outstanding: 3371677916
Book value: 103841891891.8916
P/B ratio: 0.6633486598606424
Market cap (USD): 68883379823.88
Debt to equity: 1.5811459729578534
Effective tax rate (%): 17.573423206547904
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 78882432432.43243
Capitalized R&D asset: 0
Revenue growth (%): -1.6258710359169488
Rule of 40 score: -1.6258710359169488
Financial ratios for BCS — quarterly report dated 2025-12-31
Total revenue: 9563513513.513514
Net income: 1987837837.837838
Capital expenditures: 0
Net tangible assets: 93918918918.91891
Owner earnings: 1987837837.837838
Return on net tangible assets (%): 2.1165467625899286
Buffett classification: The Gruesome
Stock price: 25.15
P/E ratio: 8.76679299171833
Shares outstanding: 3371677916
Book value: 105724324324.32422
P/B ratio: 0.8020642376230388
Market cap (USD): 84797699587.4
Debt to equity: 2.811250575182783
Effective tax rate (%): 20.87143625605164
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: 80071621621.62163
Capitalized R&D asset: 0
Revenue growth (%): -1.2557555462536674
Rule of 40 score: -1.2557555462536674
Financial ratios for BCS — annual report dated 2025-12-31
Total revenue: 39378378378.37838
Net income: 9747297297.297297
Capital expenditures: 2512162162.1621623
Operating cash flow: 25322972972.972973
Depreciation & amortization: 2372972972.972973
Net tangible assets: 93918918918.91891
Owner earnings: 9608108108.108107
Return on net tangible assets (%): 10.230215827338128
Buffett classification: The Gruesome
Stock price: 25.15
P/E ratio: 8.69961149239928
Shares outstanding: 3371677916
Book value: 105724324324.32422
P/B ratio: 0.8020642376230388
Market cap (USD): 84797699587.4
Debt to equity: 2.811250575182783
Effective tax rate (%): 21.074515811357916
COGS to revenue (%): 0
SG&A to revenue (%): 9.365133836650651
Free cash flow (dilution-adjusted): 22810810810.81081
Buyback yield (%): 9.93461422339821
Retained earnings: 80071621621.62163
Capitalized R&D asset: 0
FCF margin (%): 57.927247769389155
Revenue growth (%): 20.101802145263832
Rule of 40 score: 78.02904991465299
Financial ratios for BGE.AX — annual report dated 2023-06-30
Total revenue: 936572.1854304635
Gross profit: 936572.1854304635
Operating income: -2426844.3708609273
Net income: -3090066.2251655627
Capital expenditures: 3311.2582781456954
Depreciation & amortization: 287144.37086092716
Net tangible assets: 896026.4900662252
Owner earnings: -2806233.1125827814
Return on net tangible assets (%): -313.18640059127864
Buffett classification: The Gruesome
Stock price: 0.019867549668874173
Shares outstanding: 199859200
Book value: 798093.3774834438
P/B ratio: 4.975248128611151
Market cap (USD): 3970712.5827814573
Debt to equity: 0
Current ratio: 2.3527050270989522
Quick ratio: 2.3527050270989522
Interest coverage ratio: -916.13375
COGS to revenue (%): 0
SG&A to revenue (%): 144.76603423502928
Free cash flow (dilution-adjusted): -1933112.5827814569
Buyback yield (%): 0
Retained earnings: -2621854.304635762
Receivables turnover: 5.485379164290951
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -304.0802541819452
FCF margin (%): -206.40294606794964
Rule of 40 score: -206.40294606794964
Financial ratios for BGE.AX — annual report dated 2024-06-30
Total revenue: 778252.6666666666
Gross profit: 778252.6666666666
Operating income: -1840894.6666666667
Net income: -1546453.3333333333
Capital expenditures: 0
Depreciation & amortization: 288
Net tangible assets: 1056906
Owner earnings: -1546165.3333333333
Return on net tangible assets (%): -146.2916601224076
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 199859200
Book value: 1106655.3333333333
P/B ratio: 1.2039834142879777
Market cap (USD): 1332394.6666666667
Debt to equity: 0
Current ratio: 2.8038130260791565
Quick ratio: 2.8038130260791565
Interest coverage ratio: -461.76287625418064
COGS to revenue (%): 0
SG&A to revenue (%): 110.76025866492374
Free cash flow (dilution-adjusted): -1663670
Buyback yield (%): 0
Retained earnings: -4153236
Receivables turnover: 1.7621160868062316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -166.34760717429035
FCF margin (%): -213.76990677406397
Revenue growth (%): -16.90414484079844
Rule of 40 score: -230.6740516148624
Financial ratios for BRFH — annual report dated 2021-12-31
Capital expenditures: 151000
Buffett classification: The Gruesome
Stock price: 6.55
Shares outstanding: 16143501
Market cap (USD): 105739931.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFH — annual report dated 2022-12-31
Total revenue: 9162000
Gross profit: 1440000
Operating income: -5388000
Net income: -6134000
Capital expenditures: 13000
Operating cash flow: -2648000
Depreciation & amortization: 444000
Net tangible assets: 2627000
Owner earnings: -5703000
Return on net tangible assets (%): -217.0917396269509
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 16143501
Book value: 2933000
P/B ratio: 7.155319229457893
Market cap (USD): 20986551.3
Debt to equity: 0.006818956699624957
Current ratio: 1.7002332814930015
Quick ratio: 1.2927682737169517
COGS to revenue (%): 84.28290766208252
R&D to revenue (%): 4.1693953285308885
SG&A to revenue (%): 65.7934948701157
Free cash flow (dilution-adjusted): -3220000
Buyback yield (%): 0
Retained earnings: -57972000
Inventory turnover: 7.3683206106870225
Receivables turnover: 40.36123348017621
Capitalized R&D asset: 382000
ROCI (R&D-adjusted, %): -154.85168426344896
FCF margin (%): -35.1451648111766
Rule of 40 score: -35.1451648111766
Financial ratios for BRFH — annual report dated 2023-12-31
Total revenue: 8127000
Gross profit: 2884000
Operating income: -2816000
Net income: -2824000
Capital expenditures: 0
Operating cash flow: -2940000
Depreciation & amortization: 403000
Net tangible assets: 2262000
Owner earnings: -2421000
Return on net tangible assets (%): -107.0291777188329
Buffett classification: The Gruesome
Stock price: 1.59
Shares outstanding: 16143501
Book value: 2503000
P/B ratio: 10.254960683180185
Market cap (USD): 25668166.59
Debt to equity: 0
Current ratio: 1.8001733853489381
Quick ratio: 1.2739488513220634
Interest coverage ratio: -352
COGS to revenue (%): 64.51335055986219
R&D to revenue (%): 1.415036298757229
SG&A to revenue (%): 63.799680078749844
Free cash flow (dilution-adjusted): -3513000
Buyback yield (%): 0
Retained earnings: -60796000
Inventory turnover: 4.318780889621087
Receivables turnover: 8.284403669724771
Capitalized R&D asset: 370940
ROCI (R&D-adjusted, %): -99.7469211836944
Rosenberg metric: 3.7801047120418847
FCF margin (%): -43.22628276116649
Revenue growth (%): -11.296660117878192
Rule of 40 score: -54.52294287904468
Financial ratios for BRFH — quarterly report dated 2024-09-30
Capital expenditures: 57000
Buffett classification: The Gruesome
Stock price: 2.91
Shares outstanding: 16143501
Market cap (USD): 46977587.910000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFH — annual report dated 2024-12-31
Total revenue: 10717000
Gross profit: 3668000
Operating income: -2773000
Net income: -2825000
Capital expenditures: 53000
Operating cash flow: -2229000
Depreciation & amortization: 283000
Net tangible assets: 400000
Owner earnings: -2595000
Return on net tangible assets (%): -648.75
Buffett classification: The Gruesome
Stock price: 2.94
Shares outstanding: 16143501
Book value: 578000
P/B ratio: 82.11400162629758
Market cap (USD): 47461892.94
Debt to equity: 1.439446366782007
Current ratio: 1.040902140672783
Quick ratio: 0.4675076452599388
Interest coverage ratio: -53.32692307692308
COGS to revenue (%): 65.77400391900719
R&D to revenue (%): 1.2316879723803302
SG&A to revenue (%): 56.45236540076514
Free cash flow (dilution-adjusted): -3066000
Buyback yield (%): 0
Retained earnings: -63621000
Inventory turnover: 4.699333333333334
Receivables turnover: 12.123303167420815
Capitalized R&D asset: 335110
ROCI (R&D-adjusted, %): -274.86637547286847
Rosenberg metric: 6.817391304347826
FCF margin (%): -28.608752449379494
Revenue growth (%): 31.869078380706288
Rule of 40 score: 3.2603259313267934
Financial ratios for BRFH — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.94
Shares outstanding: 16143501
Market cap (USD): 47461892.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRFH — quarterly report dated 2025-03-31
Total revenue: 2930000
Gross profit: 900000
Operating income: -738000
Net income: -761000
Capital expenditures: 28000
Operating cash flow: -506000
Depreciation & amortization: 74000
Net tangible assets: 2632000
Owner earnings: -715000
Return on net tangible assets (%): -27.16565349544073
Buffett classification: The Gruesome
Stock price: 3.05
Shares outstanding: 16143501
Book value: 2789000
P/B ratio: 17.654240964503405
Market cap (USD): 49237678.05
Debt to equity: 0.07171029042667623
Current ratio: 1.9583843329253365
Quick ratio: 1.4981640146878825
Interest coverage ratio: -32.08695652173913
COGS to revenue (%): 69.28327645051195
R&D to revenue (%): 0.6484641638225256
SG&A to revenue (%): 52.969283276450504
Free cash flow (dilution-adjusted): -692000
Buyback yield (%): 0
Retained earnings: -64382000
Inventory turnover: 1.799645390070922
Receivables turnover: 1.818746120422098
Capitalized R&D asset: 19000
ROCI (R&D-adjusted, %): -24.968445209409065
FCF margin (%): -23.61774744027304
Rule of 40 score: -23.61774744027304
Financial ratios for BRFH — quarterly report dated 2025-06-30
Total revenue: 1625000
Gross profit: 506000
Operating income: -868000
Net income: -880000
Capital expenditures: 66000
Operating cash flow: -1069000
Depreciation & amortization: 75000
Net tangible assets: 1911000
Owner earnings: -871000
Return on net tangible assets (%): -45.57823129251701
Buffett classification: The Gruesome
Stock price: 3.42
Shares outstanding: 16143501
Book value: 2047000
P/B ratio: 26.971555163654127
Market cap (USD): 55210773.42
Debt to equity: 0.08597948216902784
Current ratio: 1.970321017565112
Quick ratio: 0.854633555420957
Interest coverage ratio: -72.33333333333333
COGS to revenue (%): 68.86153846153846
R&D to revenue (%): 1.9076923076923078
SG&A to revenue (%): 78.52307692307691
Free cash flow (dilution-adjusted): -1274000
Buyback yield (%): 0
Retained earnings: -65262000
Inventory turnover: 0.6074918566775245
Receivables turnover: 2.8359511343804535
Capitalized R&D asset: 43730
ROCI (R&D-adjusted, %): -39.52654575649117
Rosenberg metric: -20.736842105263158
FCF margin (%): -78.4
Revenue growth (%): -44.53924914675768
Rule of 40 score: -122.93924914675769
Financial ratios for BRFH — quarterly report dated 2025-09-30
Total revenue: 4231000
Gross profit: 1552000
Operating income: -260000
Net income: -290000
Capital expenditures: 52000
Operating cash flow: -598000
Depreciation & amortization: 36000
Net tangible assets: 1796000
Owner earnings: -306000
Return on net tangible assets (%): -17.037861915367483
Buffett classification: The Gruesome
Stock price: 3.48
Shares outstanding: 16143501
Book value: 1921000
P/B ratio: 29.244863862571577
Market cap (USD): 56179383.48
Debt to equity: 1.2139510671525247
Current ratio: 1.248019366197183
Quick ratio: 1.0116637323943662
Interest coverage ratio: -8.666666666666666
COGS to revenue (%): 63.31836445284803
R&D to revenue (%): 0.779957456865989
SG&A to revenue (%): 41.40865043724888
Free cash flow (dilution-adjusted): -710000
Buyback yield (%): 0
Retained earnings: -65552000
Inventory turnover: 2.494413407821229
Receivables turnover: 1.6585652685221481
Capitalized R&D asset: 60040
ROCI (R&D-adjusted, %): -11.019569832917936
Rosenberg metric: 33.74193548387097
FCF margin (%): -16.78090285984401
Revenue growth (%): 160.36923076923077
Rule of 40 score: 143.58832790938675
Financial ratios for BRFH — annual report dated 2025-12-31
Total revenue: 14208000
Gross profit: 3114000
Operating income: -2914000
Net income: -2694000
Capital expenditures: 123000
Operating cash flow: -1666000
Depreciation & amortization: 255000
Net tangible assets: 1205000
Owner earnings: -2562000
Return on net tangible assets (%): -212.61410788381744
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 16143501
Book value: 1330000
P/B ratio: 35.56425408270677
Market cap (USD): 47300457.93
Debt to equity: 3.7
Current ratio: 0.38331822302810514
Quick ratio: 0.23236627379873073
Interest coverage ratio: -13.428571428571429
COGS to revenue (%): 78.08277027027027
R&D to revenue (%): 0.9009009009009009
SG&A to revenue (%): 40.273085585585584
Free cash flow (dilution-adjusted): -2325000
Buyback yield (%): 0
Retained earnings: -66315000
Inventory turnover: 6.663063063063063
Receivables turnover: 6.910505836575876
Capitalized R&D asset: 254390
ROCI (R&D-adjusted, %): -141.69656199650504
Rosenberg metric: -4.196969696969697
FCF margin (%): -16.36402027027027
Revenue growth (%): 32.57441448166464
Rule of 40 score: 16.21039421139437
Financial ratios for BRFH — quarterly report dated 2025-12-31
Total revenue: 5422000
Gross profit: 156000
Operating income: -1048000
Net income: -763000
Capital expenditures: 81000
Operating cash flow: 507000
Depreciation & amortization: 70000
Net tangible assets: 1205000
Owner earnings: -774000
Return on net tangible assets (%): -64.23236514522821
Buffett classification: The Gruesome
Stock price: 2.93
Shares outstanding: 16143501
Book value: 1330000
P/B ratio: 35.56425408270677
Market cap (USD): 47300457.93
Debt to equity: 3.7
Current ratio: 0.38331822302810514
Quick ratio: 0.23236627379873073
Interest coverage ratio: -6.894736842105263
COGS to revenue (%): 97.12283290298784
R&D to revenue (%): 0.8483954260420509
SG&A to revenue (%): 21.04389524160826
Free cash flow (dilution-adjusted): 351000
Buyback yield (%): 0
Retained earnings: -66315000
Inventory turnover: 3.1627627627627626
Receivables turnover: 2.63715953307393
Capitalized R&D asset: 78340
ROCI (R&D-adjusted, %): -55.29705307168386
Rosenberg metric: -42.303030303030305
FCF margin (%): 6.473625968277388
Revenue growth (%): 28.149373670527062
Rule of 40 score: 34.62299963880445
Financial ratios for BV3.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.125
Shares outstanding: 75678137
Market cap (USD): 3112263384.125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BV3.DE — annual report dated 2022-12-31
Total revenue: 452050645.6241033
Gross profit: 244083500.7173601
Operating income: -10155667.144906744
Net income: -49839598.27833573
Capital expenditures: 51828407.4605452
Operating cash flow: 31571449.067431852
Depreciation & amortization: 57280774.748923965
Net tangible assets: 173220946.9153515
Owner earnings: -44387230.98995696
Return on net tangible assets (%): -25.624632459518782
Buffett classification: The Gruesome
Stock price: 30.79787234042553
Shares outstanding: 75678137
Book value: 1025823098.995696
P/B ratio: 2.272054123726661
Market cap (USD): 2330725602.287234
Debt to equity: 0.24606086696381405
Current ratio: 1.9606092666590889
Quick ratio: 1.5588010527512308
Interest coverage ratio: -0.591407731704668
COGS to revenue (%): 46.00527549731132
R&D to revenue (%): 37.549023372846136
SG&A to revenue (%): 18.692278420067584
Free cash flow (dilution-adjusted): -173716786.22668582
Buyback yield (%): 0.0574201883231467
Retained earnings: 903956241.0329986
Inventory turnover: 1.5771680564743566
Receivables turnover: 6.022791004406044
Capitalized R&D asset: 169740602.5824964
ROCI (R&D-adjusted, %): 6.360796732665319
FCF margin (%): -38.428611463844184
Rule of 40 score: -38.428611463844184
Financial ratios for BV3.DE — annual report dated 2023-12-31
Total revenue: 1049381872.2139672
Gross profit: 683959286.7756314
Operating income: 223259881.1292719
Net income: 219195988.11292717
Capital expenditures: 21177563.150074292
Operating cash flow: 166301040.1188707
Depreciation & amortization: 82291381.87221396
Net tangible assets: 573283209.5096582
Owner earnings: 280309806.83506685
Return on net tangible assets (%): 48.89552008244268
Capex to operating income (%): 9.485610689639337
Buffett classification: The Great
Stock price: 28.426966292134832
P/E ratio: 9.814503760179395
Shares outstanding: 75678137
Book value: 1536394056.4635959
P/B ratio: 1.4002266153660663
Market cap (USD): 2151299849.550562
Debt to equity: 0.014052510209931746
Current ratio: 1.9380577064417304
Quick ratio: 1.3484546799006696
Effective tax rate (%): 0.5228791666301403
Interest coverage ratio: 14.239511367620997
COGS to revenue (%): 34.82265084943517
R&D to revenue (%): 31.548750130976423
SG&A to revenue (%): 12.353228533318985
Free cash flow (dilution-adjusted): 12826745.91381872
Buyback yield (%): 0.062079334514612956
Retained earnings: 1386330163.447251
Inventory turnover: 1.4961611840344191
Receivables turnover: 3.9718374178338274
Capitalized R&D asset: 444793068.5148194
ROCI (R&D-adjusted, %): 17.907661846594493
Rosenberg metric: 2.59145884582615
FCF margin (%): 1.2223144170345805
Revenue growth (%): 132.1381204455942
Rule of 40 score: 133.36043486262878
Financial ratios for BV3.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.426966292134832
Shares outstanding: 75678137
Market cap (USD): 2151299849.550562
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BV3.DE — annual report dated 2024-12-31
Total revenue: 797239330.543933
Gross profit: 393132217.57322174
Operating income: 131069735.0069735
Net income: 137793165.9693166
Capital expenditures: 11528730.822873082
Operating cash flow: 271943096.2343096
Depreciation & amortization: 87154811.71548118
Net tangible assets: 708182566.2482567
Owner earnings: 213419246.86192468
Return on net tangible assets (%): 30.136190444867513
Capex to operating income (%): 8.795875586579696
Buffett classification: The Great
Stock price: 28.426966292134832
P/E ratio: 15.612529361794381
Shares outstanding: 75678137
Book value: 1591152161.785216
P/B ratio: 1.3520390451764714
Market cap (USD): 2151299849.550562
Debt to equity: 0.01124155798439435
Current ratio: 2.0689958698723783
Quick ratio: 1.2369249569540024
Effective tax rate (%): -1.7110084140022668
Interest coverage ratio: 12.068137456338608
COGS to revenue (%): 50.68830619470327
R&D to revenue (%): 15.088854390482078
SG&A to revenue (%): 7.983354693655198
Free cash flow (dilution-adjusted): 25595955.369595543
Buyback yield (%): 0.17801828572482786
Retained earnings: 1455257601.11576
Inventory turnover: 1.2449777833540796
Receivables turnover: 4.861777733928474
Capitalized R&D asset: 398123479.9872983
ROCI (R&D-adjusted, %): 2.197593857314023
Rosenberg metric: -0.8784541738771576
FCF margin (%): 3.2105735867461744
Revenue growth (%): -24.027720351035637
Rule of 40 score: -20.81714676428946
Financial ratios for BV3.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.426966292134832
Shares outstanding: 75678137
Market cap (USD): 2151299849.550562
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BV3.DE — quarterly report dated 2025-03-31
Total revenue: 195441219.1582003
Gross profit: 98787227.86647315
Operating income: 37574165.45718433
Net income: 31750217.706821483
Capital expenditures: 407547.1698113208
Operating cash flow: -56175471.69811321
Depreciation & amortization: 23317997.09724238
Net tangible assets: 771952104.4992744
Owner earnings: 54660667.63425254
Return on net tangible assets (%): 7.0808366627497055
Capex to operating income (%): 1.084647296493437
Buffett classification: The Great
Stock price: 28.426966292134832
P/E ratio: 16.939252743205273
Shares outstanding: 75678137
Book value: 1677270391.8722787
P/B ratio: 1.282619582373442
Market cap (USD): 2151299849.550562
Debt to equity: 0.010120718462932162
Current ratio: 2.809616497565002
Quick ratio: 1.4433360960587454
Effective tax rate (%): 4.700106295850977
Interest coverage ratio: 25.30902336494281
COGS to revenue (%): 49.45425110835518
R&D to revenue (%): 12.781321708909172
SG&A to revenue (%): 18.539124752151732
Free cash flow (dilution-adjusted): -113713497.8229318
Buyback yield (%): 1.0127943734199554
Retained earnings: 1526214949.2017417
Inventory turnover: 0.26967850986086944
Receivables turnover: 1.151379382580405
Capitalized R&D asset: 24979970.972423803
ROCI (R&D-adjusted, %): 3.1350624141682824
FCF margin (%): -58.18296586191789
Rule of 40 score: -58.18296586191789
Financial ratios for BV3.DE — quarterly report dated 2025-06-30
Total revenue: 259670283.0188679
Gross profit: 143651257.8616352
Operating income: 58327672.95597484
Net income: 57007704.40251572
Capital expenditures: 8906446.540880503
Operating cash flow: 199689622.6415094
Depreciation & amortization: 26857232.704402514
Net tangible assets: 930818553.4591194
Owner earnings: 74958490.56603773
Return on net tangible assets (%): 8.052964811184312
Capex to operating income (%): 15.269675763685964
Buffett classification: The Great
Stock price: 28.426966292134832
P/E ratio: 24.237834758011406
Shares outstanding: 75678137
Book value: 1894559748.4276726
P/B ratio: 1.1355143860392696
Market cap (USD): 2151299849.550562
Debt to equity: 0.011291184623300747
Current ratio: 3.3453493414688142
Quick ratio: 1.7405020182017235
Effective tax rate (%): 2.8878990547768724
Interest coverage ratio: 236.2828025477707
COGS to revenue (%): 44.679361769248985
R&D to revenue (%): 17.756976523808916
SG&A to revenue (%): 15.101456067594189
Free cash flow (dilution-adjusted): 70340880.50314465
Buyback yield (%): 0
Retained earnings: 1711415723.27044
Inventory turnover: 0.27886827735919795
Receivables turnover: 1.8264373421984228
Capitalized R&D asset: 62846171.746492505
ROCI (R&D-adjusted, %): 4.056986044041374
Rosenberg metric: 1.7960000852158278
FCF margin (%): 27.088536926666194
Revenue growth (%): 32.8636221864116
Rule of 40 score: 59.95215911307779
Financial ratios for BV3.DE — quarterly report dated 2025-09-30
Total revenue: 282218553.4591195
Gross profit: 140420283.0188679
Operating income: 181533805.03144655
Net income: 171831289.3081761
Capital expenditures: 7344496.855345911
Operating cash flow: 203440094.33962262
Depreciation & amortization: 26878773.584905658
Net tangible assets: 1122328616.3522012
Owner earnings: 191365566.03773585
Return on net tangible assets (%): 17.050760646174496
Capex to operating income (%): 4.045801196131842
Buffett classification: The Great
Stock price: 27.494117647058825
P/E ratio: 7.984611452906827
Shares outstanding: 75678137
Book value: 2069048113.2075472
P/B ratio: 1.0056332613564114
Market cap (USD): 2080703601.9882355
Debt to equity: 0.010186223330906125
Current ratio: 3.8366836368335995
Quick ratio: 2.4342895787502834
Effective tax rate (%): 6.583414824287267
Interest coverage ratio: 840.8994901675165
COGS to revenue (%): 50.244134803416316
R&D to revenue (%): 7.420817756879175
SG&A to revenue (%): 23.14372308360865
Free cash flow (dilution-adjusted): 193178459.11949685
Buyback yield (%): 0
Retained earnings: 1897486949.6855345
Inventory turnover: 0.35823389751467055
Receivables turnover: 1.4636471348995823
Capitalized R&D asset: 60079741.049830675
ROCI (R&D-adjusted, %): 7.948385659993207
Rosenberg metric: -0.07007164364363005
FCF margin (%): 68.44995013677566
Revenue growth (%): 8.683423523905201
Rule of 40 score: 77.13337366068086
Financial ratios for BV3.DE — quarterly report dated 2025-12-31
Total revenue: 228137264.1509434
Gross profit: 88250628.9308176
Operating income: 3143867.9245283017
Net income: -46980660.37735849
Capital expenditures: 15585534.591194969
Operating cash flow: 85699213.83647798
Depreciation & amortization: 33325157.2327044
Net tangible assets: 1086545283.018868
Owner earnings: -29241037.735849056
Return on net tangible assets (%): -2.691193656890716
Capex to operating income (%): 495.74393598399604
Buffett classification: The Gruesome
Stock price: 30.188235294117646
P/E ratio: 10.695215127165046
Shares outstanding: 75678137
Book value: 2023597169.8113205
P/B ratio: 1.1289744028400104
Market cap (USD): 2284589406.3764706
Debt to equity: 0.010168547541048314
Current ratio: 4.217343839591768
Quick ratio: 2.643709265087723
Effective tax rate (%): 1159.8645005675369
Interest coverage ratio: 9.172018348623853
COGS to revenue (%): 61.316872427983526
R&D to revenue (%): 12.52535402594019
SG&A to revenue (%): -13.749101452631477
Free cash flow (dilution-adjusted): 60632861.63522012
Buyback yield (%): 0
Retained earnings: 1858081289.308176
Inventory turnover: 0.35390121956992243
Receivables turnover: 1.8594857349371652
Capitalized R&D asset: 57822924.52830189
ROCI (R&D-adjusted, %): -0.007273954799241797
Rosenberg metric: -2.4910395879787077
FCF margin (%): 26.57735984556357
Revenue growth (%): -19.162910675187057
Rule of 40 score: 7.414449170376514
Financial ratios for BV3.DE — annual report dated 2025-12-31
Total revenue: 981754088.0503144
Gross profit: 479341666.6666666
Operating income: 283710691.8238993
Net income: 216254402.51572326
Capital expenditures: 32277987.421383645
Operating cash flow: 427972169.8113207
Depreciation & amortization: 112322327.04402515
Net tangible assets: 1086545283.018868
Owner earnings: 296298742.1383648
Return on net tangible assets (%): 27.269801523147336
Capex to operating income (%): 11.377078253158945
Buffett classification: The Great
Stock price: 30.188235294117646
P/E ratio: 10.564360215558452
Shares outstanding: 75678137
Book value: 2023597169.8113205
P/B ratio: 1.1289744028400104
Market cap (USD): 2284589406.3764706
Debt to equity: 0.010168547541048314
Current ratio: 4.217343839591768
Quick ratio: 2.643709265087723
Effective tax rate (%): 23.63062930500762
Interest coverage ratio: 161.3664818458236
COGS to revenue (%): 51.174976249031864
R&D to revenue (%): 12.496933034121318
SG&A to revenue (%): 10.749707397041233
Free cash flow (dilution-adjusted): 200962578.6163522
Buyback yield (%): 1.033180437225596
Retained earnings: 1858081289.308176
Inventory turnover: 1.2710604438726945
Receivables turnover: 8.002014614929168
Capitalized R&D asset: 312538385.08101356
ROCI (R&D-adjusted, %): 8.91324872646735
Rosenberg metric: 0.7166545895120054
FCF margin (%): 20.469747064200966
Revenue growth (%): 23.144211585809796
Rule of 40 score: 43.61395865001076
Financial ratios for CBA.L — annual report dated 2021-12-31
Capital expenditures: 15948.648648648648
Depreciation & amortization: 40259.45945945946
Buffett classification: The Gruesome
Stock price: 0.008648648648648649
Shares outstanding: 165205891
Market cap (USD): 1428807.705945946
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBA.L — annual report dated 2022-12-31
Total revenue: -1734083.1325301207
Net income: -13596169.879518073
Capital expenditures: 6907.228915662651
Operating cash flow: 8692793.975903615
Depreciation & amortization: 29251.807228915663
Net tangible assets: 171178921.68674698
Owner earnings: -13573825.301204821
Return on net tangible assets (%): -7.929612575808003
Buffett classification: The Gruesome
Stock price: 0.004939759036144578
Shares outstanding: 165205891
Book value: 218699368.6746988
P/B ratio: 0.003731502737465276
Market cap (USD): 816077.2928915662
Debt to equity: 0.16863965804056177
Free cash flow (dilution-adjusted): 8685886.746987952
Buyback yield (%): 0
Retained earnings: 39178846.98795181
Receivables turnover: -0.39711831114856166
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBA.L — annual report dated 2023-12-31
Total revenue: 3353427.8481012657
Net income: 19889897.46835443
Capital expenditures: 131950.6329113924
Operating cash flow: 5538424.050632911
Depreciation & amortization: 29311.39240506329
Net tangible assets: 200657656.9620253
Owner earnings: 19787258.2278481
Return on net tangible assets (%): 9.861202670971515
Buffett classification: The Gruesome
Stock price: 0.003924050632911392
P/E ratio: 0.032593243990858785
Shares outstanding: 165205891
Book value: 261862841.7721519
P/B ratio: 0.002475632956367703
Market cap (USD): 648276.2811392404
Debt to equity: 0.1628910912367908
Effective tax rate (%): 0
COGS to revenue (%): 0
SG&A to revenue (%): 110.8402964206661
Free cash flow (dilution-adjusted): 5406473.417721518
Buyback yield (%): 0
Retained earnings: 59083845.56962025
Receivables turnover: 0.2572013889920429
Capitalized R&D asset: 0
FCF margin (%): 161.22229738095308
Rule of 40 score: 161.22229738095308
Financial ratios for CBA.L — annual report dated 2024-12-31
Total revenue: -33945640
Net income: -35688353.75
Capital expenditures: 0
Operating cash flow: 3269183.75
Depreciation & amortization: 0
Net tangible assets: 162461082.5
Owner earnings: -35688353.75
Return on net tangible assets (%): -21.967324851476352
Buffett classification: The Gruesome
Stock price: 0.0029999999999999996
Shares outstanding: 165205891
Book value: 162461082.5
P/B ratio: 0.0030506855264860124
Market cap (USD): 495617.67299999995
Debt to equity: 0.1998363208000907
Free cash flow (dilution-adjusted): 3269183.75
Buyback yield (%): 0
Retained earnings: 29163553.75
Receivables turnover: -34.08000040158324
Capitalized R&D asset: 0
Revenue growth (%): -1112.266896370538
Rule of 40 score: -1112.266896370538
Financial ratios for CBA.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 162461082.5
Buffett classification: The Gruesome
Stock price: 0.0029999999999999996
Shares outstanding: 165205891
Book value: 162461082.5
P/B ratio: 0.0030506855264860124
Market cap (USD): 495617.67299999995
Debt to equity: 0.1998363208000907
Buyback yield (%): 0
Retained earnings: 29163553.75
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHGG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.7
Shares outstanding: 111958838
Market cap (USD): 3437136326.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHGG — annual report dated 2022-12-31
Total revenue: 766897000
Gross profit: 569501000
Operating income: 8957000
Net income: 266638000
Capital expenditures: 103092000
Operating cash flow: 255736000
Depreciation & amortization: 91607000
Net tangible assets: 423163000
Owner earnings: 255153000
Return on net tangible assets (%): 60.29662328700761
Capex to operating income (%): 1150.9657251311824
Buffett classification: The Gruesome
Stock price: 25.27
P/E ratio: 10.610640029778201
Shares outstanding: 111958838
Book value: 1116589000
P/B ratio: 2.5337880242954207
Market cap (USD): 2829199836.2599998
Debt to equity: 1.0764641242211772
Current ratio: 8.240563388395236
Quick ratio: 8.240563388395236
Effective tax rate (%): -156.5158832470706
Interest coverage ratio: 1.4829470198675496
COGS to revenue (%): 25.739571285322537
R&D to revenue (%): 25.640601019432857
SG&A to revenue (%): 47.45187424126056
Free cash flow (dilution-adjusted): 19188000
Buyback yield (%): 11.435318066032442
Retained earnings: -70553000
Receivables turnover: 32.61309802253881
Capitalized R&D asset: 196637000
ROCI (R&D-adjusted, %): 5.550471581022723
FCF margin (%): 2.5020309115826507
Rule of 40 score: 2.5020309115826507
Financial ratios for CHGG — annual report dated 2023-12-31
Total revenue: 716295000
Gross profit: 490354000
Operating income: -64125000
Net income: 18180000
Capital expenditures: 83052000
Operating cash flow: 246198000
Depreciation & amortization: 129718000
Net tangible assets: 260193000
Owner earnings: 64846000
Return on net tangible assets (%): 24.922269238603654
Buffett classification: The Gruesome
Stock price: 11.36
P/E ratio: 69.95887787018702
Shares outstanding: 111958838
Book value: 944618000
P/B ratio: 1.346419822277365
Market cap (USD): 1271852399.6799998
Debt to equity: 0.6541268533947056
Current ratio: 0.8001261423209416
Quick ratio: 0.8001261423209416
Effective tax rate (%): 63.86547940849102
Interest coverage ratio: -16.99575934269812
COGS to revenue (%): 31.543009514236452
R&D to revenue (%): 26.76341451496939
SG&A to revenue (%): 50.6458931027021
Free cash flow (dilution-adjusted): 29644000
Buyback yield (%): 26.324281031685576
Retained earnings: -52373000
Receivables turnover: 22.809037065341993
Capitalized R&D asset: 323451790
ROCI (R&D-adjusted, %): -0.12187071671992257
Rosenberg metric: -0.4025030894490864
FCF margin (%): 4.138518347887392
Revenue growth (%): -6.598278517193313
Rule of 40 score: -2.4597601693059206
Financial ratios for CHGG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.77
Shares outstanding: 111958838
Market cap (USD): 198167143.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHGG — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 19378000
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 111958838
Market cap (USD): 180253729.18
Buyback yield (%): 1.4252132323068978
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CHGG — annual report dated 2024-12-31
Total revenue: 617574000
Gross profit: 436647000
Operating income: -59869000
Net income: -837068000
Capital expenditures: 74953000
Operating cash flow: 125205000
Depreciation & amortization: 78344000
Net tangible assets: 182634000
Owner earnings: -833677000
Return on net tangible assets (%): -456.47415048676584
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 111958838
Book value: 192981000
P/B ratio: 0.9340490990304746
Market cap (USD): 180253729.18
Debt to equity: 2.614029360403356
Current ratio: 0.8281753640167998
Quick ratio: 0.8281753640167998
Interest coverage ratio: -23.115444015444016
COGS to revenue (%): 29.296408203713238
R&D to revenue (%): 27.596854789871333
SG&A to revenue (%): 52.800959884969245
Free cash flow (dilution-adjusted): -34362000
Buyback yield (%): 1.4252132323068978
Retained earnings: -889441000
Receivables turnover: 26.123006641005034
Capitalized R&D asset: 363763560
ROCI (R&D-adjusted, %): -10.74652300501834
Rosenberg metric: -0.28015440390182833
FCF margin (%): -5.564029573783871
Revenue growth (%): -13.782170753669925
Rule of 40 score: -19.346200327453797
Financial ratios for CHGG — quarterly report dated 2025-03-31
Total revenue: 121387000
Gross profit: 67414000
Operating income: -27002000
Net income: -17484000
Capital expenditures: 8665000
Operating cash flow: 24526000
Depreciation & amortization: 32094000
Net tangible assets: 176400000
Owner earnings: 5945000
Buffett classification: The Gruesome
Stock price: 0.64
Shares outstanding: 111958838
Book value: 185671000
P/B ratio: 0.38591732860812944
Market cap (USD): 71653656.32000001
Debt to equity: 0.45654948807298934
Current ratio: 1.2263845362271388
Quick ratio: 1.2263845362271388
Interest coverage ratio: -57.820128479657384
COGS to revenue (%): 44.46357517691351
R&D to revenue (%): 24.24312323395421
SG&A to revenue (%): 53.53785825500259
Free cash flow (dilution-adjusted): 4604000
Buyback yield (%): 0
Retained earnings: -906925000
Receivables turnover: 4.251882727941434
Capitalized R&D asset: 29428000
ROCI (R&D-adjusted, %): -2.4845904912534564
FCF margin (%): 3.7928278975508087
Rule of 40 score: 3.7928278975508087
Financial ratios for CHGG — quarterly report dated 2025-06-30
Total revenue: 105120000
Gross profit: 69642000
Operating income: -36458000
Net income: -35663000
Capital expenditures: 7230000
Operating cash flow: -4840000
Depreciation & amortization: 16226000
Net tangible assets: 149662000
Owner earnings: -26667000
Return on net tangible assets (%): -17.818150231855782
Buffett classification: The Gruesome
Stock price: 1.21
Shares outstanding: 111958838
Book value: 157856000
P/B ratio: 0.8581884374366512
Market cap (USD): 135470193.98
Debt to equity: 0.5374391850800729
Current ratio: 0.8984751221532455
Quick ratio: 0.8984751221532455
Interest coverage ratio: -889.219512195122
COGS to revenue (%): 33.75
R&D to revenue (%): 27.318302891933026
SG&A to revenue (%): 73.61396499238964
Free cash flow (dilution-adjusted): -19982000
Buyback yield (%): 0
Retained earnings: -942588000
Receivables turnover: 5.8222099141512045
Capitalized R&D asset: 48433760
ROCI (R&D-adjusted, %): -12.005548685799058
Rosenberg metric: 0.07571020796520321
FCF margin (%): -19.00875190258752
Revenue growth (%): -13.400940792671372
Rule of 40 score: -32.40969269525889
Financial ratios for CHGG — quarterly report dated 2025-09-30
Total revenue: 77742000
Gross profit: 46041000
Operating income: -17124000
Net income: -17471000
Capital expenditures: 5756000
Operating cash flow: 4813000
Depreciation & amortization: 15321000
Net tangible assets: 138936000
Owner earnings: -7906000
Return on net tangible assets (%): -5.6903898197731335
Buffett classification: The Gruesome
Stock price: 1.51
Shares outstanding: 111958838
Book value: 146053000
P/B ratio: 1.1575102557290846
Market cap (USD): 169057845.38
Debt to equity: 0.5685333406366182
Current ratio: 0.9476011630724497
Quick ratio: 0.9476011630724497
Interest coverage ratio: -417.6585365853659
COGS to revenue (%): 40.777186077024005
R&D to revenue (%): 23.60371485168892
SG&A to revenue (%): 57.64580278356616
Free cash flow (dilution-adjusted): -6868000
Buyback yield (%): 0
Retained earnings: -960059000
Receivables turnover: 5.035103626943005
Capitalized R&D asset: 47301630
ROCI (R&D-adjusted, %): -11.505186023786253
Rosenberg metric: -0.8218476860396281
FCF margin (%): -8.834349515062643
Revenue growth (%): -26.044520547945204
Rule of 40 score: -34.878870063007845
Financial ratios for CHGG — annual report dated 2025-12-31
Total revenue: 376908000
Gross profit: 224757000
Operating income: -114856000
Net income: -103421000
Capital expenditures: 28123000
Operating cash flow: 15490000
Depreciation & amortization: 78637000
Net tangible assets: 113582000
Owner earnings: -52907000
Return on net tangible assets (%): -46.58044408445
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 111958838
Book value: 119623000
P/B ratio: 0.8704155500196451
Market cap (USD): 104121719.34
Debt to equity: 0.5765613636173645
Current ratio: 0.8628207766039717
Quick ratio: 0.8628207766039717
Interest coverage ratio: -194.67118644067796
COGS to revenue (%): 40.368206564997294
R&D to revenue (%): 24.794644847018372
SG&A to revenue (%): 65.31036751674148
Free cash flow (dilution-adjusted): -44497000
Buyback yield (%): 0
Retained earnings: -992862000
Receivables turnover: 24.15457574980774
Capitalized R&D asset: 270904420
ROCI (R&D-adjusted, %): -42.47013185384407
Rosenberg metric: -1.2432597356114792
FCF margin (%): -11.805798762562747
Revenue growth (%): -38.96958097329227
Rule of 40 score: -50.77537973585501
Financial ratios for CHGG — quarterly report dated 2025-12-31
Total revenue: 72659000
Gross profit: 41660000
Operating income: -34272000
Net income: -32803000
Capital expenditures: 6472000
Operating cash flow: -9009000
Depreciation & amortization: 14996000
Net tangible assets: 113582000
Owner earnings: -24279000
Return on net tangible assets (%): -21.37574615696149
Buffett classification: The Gruesome
Stock price: 0.93
Shares outstanding: 111958838
Book value: 119623000
P/B ratio: 0.8704155500196451
Market cap (USD): 104121719.34
Debt to equity: 0.5765613636173645
Current ratio: 0.8628207766039717
Quick ratio: 0.8628207766039717
Interest coverage ratio: -835.9024390243902
COGS to revenue (%): 42.66367552539947
R&D to revenue (%): 23.3391596361084
SG&A to revenue (%): 81.1654440606119
Free cash flow (dilution-adjusted): -22251000
Buyback yield (%): 0
Retained earnings: -992862000
Receivables turnover: 4.656434247628813
Capitalized R&D asset: 38729110
ROCI (R&D-adjusted, %): -21.988920384339945
Rosenberg metric: -0.2387465940054496
FCF margin (%): -30.623873160929822
Revenue growth (%): -6.538293329217154
Rule of 40 score: -37.16216649014697
Financial ratios for CKT.L — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.005866666666666667
Shares outstanding: 108008562
Market cap (USD): 633650.2304
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKT.L — annual report dated 2023-01-31
Total revenue: 12716049.382716049
Gross profit: 8024691.358024691
Operating income: -10000000
Net income: -15185185.185185185
Capital expenditures: 246913.58024691357
Operating cash flow: -7901234.567901234
Depreciation & amortization: 1851851.8518518517
Net tangible assets: 18395061.72839506
Owner earnings: -13580246.913580246
Return on net tangible assets (%): -73.8255033557047
Buffett classification: The Gruesome
Stock price: 0.0029629629629629624
Shares outstanding: 108008562
Book value: 23333333.33333333
P/B ratio: 0.013715372952380952
Market cap (USD): 320025.3688888888
Debt to equity: 0.03174603174603175
Current ratio: 2.8846153846153846
Quick ratio: 2.576923076923077
COGS to revenue (%): 36.89320388349514
SG&A to revenue (%): 125.24271844660196
Free cash flow (dilution-adjusted): -10864197.530864198
Buyback yield (%): 0
Retained earnings: -20370370.37037037
Inventory turnover: 1.5833333333333333
Receivables turnover: 3.4333333333333336
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.3265306122449
FCF margin (%): -85.4368932038835
Rule of 40 score: -85.4368932038835
Financial ratios for CKT.L — annual report dated 2024-01-31
Total revenue: 15189873.417721517
Gross profit: 10126582.278481012
Operating income: -6329113.924050633
Net income: -5696202.531645569
Capital expenditures: 126582.27848101265
Operating cash flow: -5949367.088607594
Depreciation & amortization: 1772151.8987341772
Net tangible assets: 12151898.734177215
Owner earnings: -4050632.911392404
Return on net tangible assets (%): -33.33333333333333
Buffett classification: The Gruesome
Stock price: 0.002911392405063291
Shares outstanding: 108008562
Book value: 18481012.658227846
P/B ratio: 0.017015047438356166
Market cap (USD): 314455.3070886076
Debt to equity: 0.03424657534246576
Current ratio: 2.1625
Quick ratio: 1.6874999999999998
COGS to revenue (%): 33.333333333333336
SG&A to revenue (%): 95
Free cash flow (dilution-adjusted): -8860759.493670885
Buyback yield (%): 0
Retained earnings: -26582278.481012657
Inventory turnover: 1.0526315789473684
Receivables turnover: 4.285714285714286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -33.11258278145696
FCF margin (%): -58.33333333333333
Revenue growth (%): 19.45434435295563
Rule of 40 score: -38.8789889803777
Financial ratios for CKT.L — annual report dated 2025-01-31
Total revenue: 17625000
Gross profit: 12250000
Operating income: -4750000
Net income: -4500000
Capital expenditures: 250000
Operating cash flow: -1500000
Depreciation & amortization: 1875000
Net tangible assets: 6000000
Owner earnings: -2875000
Return on net tangible assets (%): -47.91666666666667
Buffett classification: The Gruesome
Stock price: 0.002125
Shares outstanding: 108008562
Book value: 13875000
P/B ratio: 0.01654185183783784
Market cap (USD): 229518.19425000003
Debt to equity: 0.05405405405405406
Current ratio: 1.5679012345679013
Quick ratio: 1.0864197530864197
COGS to revenue (%): 30.49645390070922
SG&A to revenue (%): 85.1063829787234
Free cash flow (dilution-adjusted): -4875000
Buyback yield (%): 0
Retained earnings: -30750000
Inventory turnover: 1.1025641025641026
Receivables turnover: 8.294117647058824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -32.20338983050847
FCF margin (%): -27.659574468085108
Revenue growth (%): 16.031250000000014
Rule of 40 score: -11.628324468085093
Financial ratios for CKT.L — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 6000000
Buffett classification: The Gruesome
Stock price: 0.002125
Shares outstanding: 108008562
Book value: 13875000
P/B ratio: 0.01654185183783784
Market cap (USD): 229518.19425000003
Debt to equity: 0.05405405405405406
Current ratio: 1.5679012345679013
Quick ratio: 1.0864197530864197
Buyback yield (%): 0
Retained earnings: -30750000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CKT.L — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 3066666.6666666665
Buffett classification: The Gruesome
Stock price: 0.002
Shares outstanding: 108008562
Book value: 12133333.333333332
P/B ratio: 0.017803609120879124
Market cap (USD): 216017.124
Debt to equity: 0.043956043956043966
Current ratio: 1.271604938271605
Quick ratio: 0.8395061728395062
Buyback yield (%): 0
Retained earnings: -35600000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTEK.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7874015748031495
Shares outstanding: 29315377
Market cap (USD): 23082974.015748028
Buyback yield (%): 0
Capitalized R&D asset: -683464.5669291338
Rule of 40 score: 0